NDC 0641-6022-01 - Famotidine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-6022
- Requested NDC
- 0641-6022-01
- Package NDCs from labels
- 0641-6022-01, 0641-6022-25
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Effective date
- 2024-04-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Famotidine Injection, USP | Hikma Pharmaceuticals USA Inc. | 2024-04-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Famotidine - Medical Purchasing Solutions, LLC | Medical Purchasing Solutions, LLC | 2023-05-08 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-6022-01 | Famotidine | 2 mL in 1 VIAL | INJECTION | 2 | 9 | |
| 0641-6022-25 | Famotidine | 25 in 1 CARTON | INJECTION | 25 | 9 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-6022-01 | ML - Milliliter | 0641-6022 | 14529626-4b70-42c6-a890-9b69073ec03a | 1 | 2013-02-13 |
| 0641-6022-25 | ML - Milliliter | 0641-6022 | 4387b354-0e9e-4478-9b06-72f87bf78c58 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| FAMOTIDINE | ACTIVE INGREDIENT | 5QZO15J2Z8 | FAMOTIDINE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| FAMOTIDINE | ACTIVE MOIETY | 5QZO15J2Z8 | FAMOTIDINE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| ASPARTIC ACID | INACTIVE INGREDIENT | 30KYC7MIAI | FAMOTIDINE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | FAMOTIDINE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | FAMOTIDINE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | FAMOTIDINE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Original strength heartburn prevention | FAMOTIDINE | KROGER COMPANY | ea1c2838-acbd-18e0-e053-2a95a90a3522 | 2024-07-08 | Warnings | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Contract Pharmacal Corp. | 273deac8-c2b0-423f-8662-4f16d91df216 | 2024-07-04 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| FAMOTIDINE | FAMOTIDINE | NuCare Pharmaceuticals,Inc. | fd271deb-c748-bf26-e053-6294a90a11aa | 2024-06-28 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| Eyesaline Emergency Eyewash | PURIFIED WATER | Honeywell Safety Products USA, Inc. | ad42a7e3-84ea-390d-e053-2a95a90a3a32 | 2024-06-14 | Warnings | 059QF0KO0R |
| Famotidine | FAMOTIDINE | NuCare Pharmaceuticals,Inc. | 60cd0973-f74e-2b70-e053-2a91aa0a4361 | 2024-06-06 | Adverse reactions | 5QZO15J2Z8 |
| Eyes Alive Eye Wash | WATER | RIVIERA PHARMA INC | 081079f4-1c06-4054-b771-00fedaa666f6 | 2024-06-05 | Warnings | 059QF0KO0R |
| Famotidine | FAMOTIDINE | A-S Medication Solutions | 0abfc8e6-7fdf-4828-89f4-2202002f8489 | 2024-06-03 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | A-S Medication Solutions | 75a334ee-48b9-47e7-8225-6e595bed8a74 | 2024-06-03 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| Pepcid | FAMOTIDINE | Bausch Health US LLC | a06502d9-7903-4f37-833e-e5763d502def | 2024-06-01 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| Sterile Water | WATER | Becton Dickinson and Company | 6e43c5a3-dad2-49ed-b500-964cb4563cc9 | 2024-05-31 | Warnings, Adverse reactions | 059QF0KO0R |
| Famotidine | FAMOTIDINE | Rising Pharma Holdings, Inc. | 15b87f7f-1abf-4d8a-bdbe-03bea0021a68 | 2024-05-29 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | VKT Pharma Private Limited | 1c2cfb3c-eaa0-403f-9589-d706afc06f51 | 2024-05-22 | Warnings | 5QZO15J2Z8 |
| Maximum Strength Acid Reducer | FAMOTIDINE | TARGET CORPORATION | 07a924f1-14cc-4e7d-e063-6394a90ac7f3 | 2024-05-13 | Warnings | 5QZO15J2Z8 |
| Walgreens Lidocaine Plus Cream | BENZYL ALCOHOL AND LIDOCAINE HYDROCHLORIDE | Walgreens Company | e33e0097-31d6-8083-e053-2a95a90af5d2 | 2024-05-09 | Warnings | LKG8494WBH |
| HealthWise Lidocaine Plus Cream | BENZYL ALCOHOL, LIDOCAINE HYDROCHLORIDE | Veridian Healthcare | 16f26249-b508-2c6e-e063-6394a90a265b | 2024-04-25 | Warnings | LKG8494WBH |
| IBUPROFEN AND FAMOTIDINE | IBUPROFEN AND FAMOTIDINE | Advanced Rx Pharmacy of Tennessee, LLC | 16c8b0db-37d0-99d9-e063-6394a90ac31b | 2024-04-23 | Boxed warning, Warnings, Adverse reactions | 5QZO15J2Z8 |
| PEMF Optimizer | AQUA SULIS, ARGENTUM METALLICUM, AURUM METALLICUM, CUPRUM METALLICUM, LAPIS ALBUS, MANGANUM METALLICUM VANADIUM METALLICUM VISCUM ALBUM, ZINCUM METALLICUM | Deseret Biologicals, Inc. | 97d57469-4c5b-4d3f-9398-3a1a6617a649 | 2024-04-23 | Warnings | 059QF0KO0R |
| Pepcid Complete | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | Navajo Manufacturing Company Inc | ac3cd760-4615-117b-e053-2a95a90a8d42 | 2024-04-15 | Warnings | 5QZO15J2Z8 |
| Zantac 360 | FAMOTIDINE | Navajo Manufacturing Company Inc. | e328c59c-baed-0e4e-e053-2995a90ab85c | 2024-04-15 | Warnings | 5QZO15J2Z8 |
| FAMOTIDINE | FAMOTIDINE | Asclemed USA, Inc. | 69bd5340-298b-46ca-83c7-0b5ef233f9c5 | 2024-04-12 | Warnings, Adverse reactions | 5QZO15J2Z8 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.